International Stem Cell Corporation (ISCO)
OTCMKTS · Delayed Price · Currency is USD
0.1500
0.00 (0.00%)
Aug 22, 2025, 4:00 PM EDT
International Stem Cell Revenue
International Stem Cell had revenue of $2.45M in the quarter ending June 30, 2025, with 4.98% growth. This brings the company's revenue in the last twelve months to $9.20M, up 10.56% year-over-year. In the year 2024, International Stem Cell had annual revenue of $9.09M with 16.64% growth.
Revenue (ttm)
9.20M
Revenue Growth
+10.56%
P/S Ratio
0.13
Revenue / Employee
287.53K
Employees
32
Market Cap
1.17M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.09M | 1.30M | 16.64% |
Dec 31, 2023 | 7.79M | -391.00K | -4.78% |
Dec 31, 2022 | 8.18M | 1.00M | 13.99% |
Dec 31, 2021 | 7.18M | 48.00K | 0.67% |
Dec 31, 2020 | 7.13M | -2.34M | -24.75% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Glass House Brands | 221.55M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 105.45M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.09M |
Silence Therapeutics | 27.17M |
Global Cord Blood | 196.10M |
International Stem Cell News
- 5 months ago - International Stem Cell GAAP EPS of -$0.03, revenue of $9.09M - Seeking Alpha
- 5 months ago - International Stem Cell Corporation Announces 2024 Fourth Quarter and Year-End Results - Accesswire
- 2 years ago - Eighteenth edition of Fujio Cup Quiz won by Kasturba Medical College, India in the NCRM NICHE 2023 international stem cell meeting. - Business Wire
- 3 years ago - International Stem Cell Corporation Announces Strong Financial Results for the Quarter Ended March 31, 2022 - Accesswire